483 related articles for article (PubMed ID: 34788600)
1. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.
Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC
Immunity; 2021 Dec; 54(12):2908-2921.e6. PubMed ID: 34788600
[TBL] [Abstract][Full Text] [Related]
2. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
J Virol; 2018 May; 92(10):. PubMed ID: 29514901
[TBL] [Abstract][Full Text] [Related]
3. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
Cell Rep; 2021 Sep; 36(13):109760. PubMed ID: 34534459
[TBL] [Abstract][Full Text] [Related]
4. α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants.
Zou J; Jing H; Zhang X; Liu Y; Zhao Z; Duan L; Yuan Y; Chen Z; Gou Q; Xiong Q; Li S; Yang F; Zeng H; Zou Q; Zhang J
Front Immunol; 2021; 12():757691. PubMed ID: 34630436
[TBL] [Abstract][Full Text] [Related]
5. Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.
Zang T; Osei Kuffour E; Baharani VA; Canis M; Schmidt F; Da Silva J; Lercher A; Chaudhary P; Hoffmann HH; Gazumyan A; Miranda IC; MacDonald MR; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2317367120. PubMed ID: 38096415
[TBL] [Abstract][Full Text] [Related]
6. Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.
Wang Y; Zhang Z; Yang M; Xiong X; Yan Q; Cao L; Wei P; Zhang Y; Zhang L; Lv K; Chen J; Liu X; Zhao X; Xiao J; Zhang S; Zhu A; Gan M; Zhang J; Cai R; Zhuo J; Zhang Y; Rao H; Qu B; Zhang Y; Chen L; Dai J; Cheng L; Hu Q; Chen Y; Lv H; So RTY; Peiris M; Zhao J; Liu X; Mok CKP; Wang X; Zhao J
Cell Rep; 2024 Jan; 43(1):113653. PubMed ID: 38175758
[TBL] [Abstract][Full Text] [Related]
7. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Sankhala RS; Lal KG; Jensen JL; Dussupt V; Mendez-Rivera L; Bai H; Wieczorek L; Mayer SV; Zemil M; Wagner DA; Townsley SM; Hajduczki A; Chang WC; Chen WH; Donofrio GC; Jian N; King HAD; Lorang CG; Martinez EJ; Rees PA; Peterson CE; Schmidt F; Hart TJ; Duso DK; Kummer LW; Casey SP; Williams JK; Kannan S; Slike BM; Smith L; Swafford I; Thomas PV; Tran U; Currier JR; Bolton DL; Davidson E; Doranz BJ; Hatziioannou T; Bieniasz PD; Paquin-Proulx D; Reiley WW; Rolland M; Sullivan NJ; Vasan S; Collins ND; Modjarrad K; Gromowski GD; Polonis VR; Michael NL; Krebs SJ; Joyce MG
Nat Commun; 2024 Jan; 15(1):200. PubMed ID: 38172512
[TBL] [Abstract][Full Text] [Related]
8. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
Xiong H; Sun H; Wang S; Yuan L; Liu L; Zhu Y; Zhang J; Huang Y; Qi R; Jiang Y; Ma J; Zhou M; Ma Y; Fu R; Yan S; Yue M; Wu Y; Wei M; Wang Y; Li T; Wang Y; Zheng Z; Yu H; Cheng T; Li S; Yuan Q; Zhang J; Guan Y; Zheng Q; Zhang T; Xia N
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2204256119. PubMed ID: 35972965
[TBL] [Abstract][Full Text] [Related]
9. Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
Li K; Huntwork RHC; Horn GQ; Abraha M; Hastie KM; Li H; Rayaprolu V; Olmedillas E; Feeney E; Cronin K; Schendel SL; Heise M; Bedinger D; Mattocks MD; Baric RS; Alam SM; Ollmann Saphire E; Tomaras GD; Dennison SM
J Virol; 2023 Dec; 97(12):e0107023. PubMed ID: 38019013
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.
Martinez DR; Schäfer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Soderblom EJ; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
Cell Rep; 2023 Oct; 42(10):113248. PubMed ID: 37858337
[TBL] [Abstract][Full Text] [Related]
11. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
Liu H; Wu NC; Yuan M; Bangaru S; Torres JL; Caniels TG; van Schooten J; Zhu X; Lee CD; Brouwer PJM; van Gils MJ; Sanders RW; Ward AB; Wilson IA
Immunity; 2020 Dec; 53(6):1272-1280.e5. PubMed ID: 33242394
[TBL] [Abstract][Full Text] [Related]
12. A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Hua RH; Zhang SJ; Niu B; Ge JY; Lan T; Bu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0119023. PubMed ID: 37306579
[TBL] [Abstract][Full Text] [Related]
13. Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus.
Lee J; Zepeda SK; Park YJ; Taylor AL; Quispe J; Stewart C; Leaf EM; Treichel C; Corti D; King NP; Starr TN; Veesler D
Cell Host Microbe; 2023 Dec; 31(12):1961-1973.e11. PubMed ID: 37989312
[TBL] [Abstract][Full Text] [Related]
14. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Sankhala RS; Dussupt V; Chen WH; Bai H; Martinez EJ; Jensen JL; Rees PA; Hajduczki A; Chang WC; Choe M; Yan L; Sterling SL; Swafford I; Kuklis C; Soman S; King J; Corbitt C; Zemil M; Peterson CE; Mendez-Rivera L; Townsley SM; Donofrio GC; Lal KG; Tran U; Green EC; Smith C; de Val N; Laing ED; Broder CC; Currier JR; Gromowski GD; Wieczorek L; Rolland M; Paquin-Proulx D; van Dyk D; Britton Z; Rajan S; Loo YM; McTamney PM; Esser MT; Polonis VR; Michael NL; Krebs SJ; Modjarrad K; Joyce MG
Structure; 2024 Feb; 32(2):131-147.e7. PubMed ID: 38157856
[TBL] [Abstract][Full Text] [Related]
15. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
bioRxiv; 2021 Apr; ():. PubMed ID: 33948592
[TBL] [Abstract][Full Text] [Related]
16. Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses.
Liu C; Xu S; Zheng Y; Xie Y; Xu K; Chai Y; Luo T; Dai L; Gao GF
Cell Rep; 2024 May; 43(5):114235. PubMed ID: 38748880
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
Shi W; Wang L; Zhou T; Sastry M; Yang ES; Zhang Y; Chen M; Chen X; Choe M; Creanga A; Leung K; Olia AS; Pegu A; Rawi R; Schön A; Shen CH; Stancofski ED; Talana CA; Teng IT; Wang S; Corbett KS; Tsybovsky Y; Mascola JR; Kwong PD
Structure; 2022 Sep; 30(9):1233-1244.e7. PubMed ID: 35841885
[TBL] [Abstract][Full Text] [Related]
18. Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Chia WN; Tan CW; Tan AWK; Young B; Starr TN; Lopez E; Fibriansah G; Barr J; Cheng S; Yeoh AY; Yap WC; Lim BL; Ng TS; Sia WR; Zhu F; Chen S; Zhang J; Kwek MSS; Greaney AJ; Chen M; Au GG; Paradkar PN; Peiris M; Chung AW; Bloom JD; Lye D; Lok S; Wang LF
Sci Adv; 2023 Jul; 9(30):eade3470. PubMed ID: 37494438
[TBL] [Abstract][Full Text] [Related]
19. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
He WT; Musharrafieh R; Song G; Dueker K; Tse LV; Martinez DR; Schäfer A; Callaghan S; Yong P; Beutler N; Torres JL; Volk RM; Zhou P; Yuan M; Liu H; Anzanello F; Capozzola T; Parren M; Garcia E; Rawlings SA; Smith DM; Wilson IA; Safonova Y; Ward AB; Rogers TF; Baric RS; Gralinski LE; Burton DR; Andrabi R
Nat Immunol; 2022 Jun; 23(6):960-970. PubMed ID: 35654851
[TBL] [Abstract][Full Text] [Related]
20. Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation.
Hauser BM; Sangesland M; Lam EC; St Denis KJ; Sheehan ML; Vu ML; Cheng AH; Sordilla S; Lamson DT; Almawi AW; Balazs AB; Lingwood D; Schmidt AG
ACS Infect Dis; 2024 Feb; 10(2):553-561. PubMed ID: 38281136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
